BIOGEN INC (BIIB) Stock Cash Flow
NASDAQ:BIIB - Nasdaq - US09062X1037 - Common Stock - Currency: USD
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 1.53B | 1.63B | 1.16B | 2.96B | 1.73B | |||
| Depreciation Amortization | 744.30M | 673.20M | 494.80M | 518.40M | 487.70M | |||
| Income Taxes - Deferred | -170.10M | -158.10M | -305.80M | -168.60M | -426.80M | |||
| Change In Working Capital | -861.00M | -155.20M | -648.70M | -890.30M | -145.50M | |||
| Interest Paid | N/A | 245.40M | 252.20M | 262.50M | 280.80M | |||
| Taxes Paid | N/A | 355.10M | 740.70M | 932.90M | 247.90M | |||
| Other non cash items | 873.00M | 883.40M | 845.40M | -1.04B | 2.00B | |||
| OPERATING CASH FLOW | 2.12B | 2.88B | 1.55B | 1.38B | 3.64B | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -270.00M | -359.80M | -311.40M | -243.20M | -294.90M | |||
| Other Investing Activity | -1.03B | -439.40M | -3.79B | 1.82B | -268.80M | |||
| INVESTING CASH FLOW | -1.30B | -799.20M | -4.10B | 1.58B | -563.70M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -16.60M | -650.00M | 187.30M | -1.00B | -170.00M | |||
| Stock Issued/Repurchased | N/A | 0.00 | 0.00 | -750.00M | -1.80B | |||
| Other Financing Activity | -16.80M | -33.50M | -38.00M | 4.90M | -116.20M | |||
| FINANCING CASH FLOW | -33.40M | -683.50M | 149.30M | -1.75B | -2.09B | |||
| Exchange Rate Effect | 70.60M | -67.70M | 35.10M | -55.70M | -59.80M | |||
| CHANGE IN CASH | 849.90M | 1.33B | -2.37B | 1.16B | 930.20M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 2.12B | 2.88B | 1.55B | 1.38B | 3.64B | |||
| Capital Expenditure | -270.00M | -359.80M | -311.40M | -243.20M | -294.90M | |||
| FREE CASH FLOW | 1.85B | 2.52B | 1.24B | 1.14B | 3.35B | |||
All data in USD